DSM announces reorganisation at DSM Pharma Chemicals in Venlo, NL

16 décembre 2009 Venlo, (NL), 16 December 2009 DSM Pharma Chemicals in Venlo, the Netherlands, today announced the intention for a reorganisation that, according to plan, will lead to the loss of approximately 35 jobs. The intended reorganisation, which has been explained to and for which advice from the local works council has been requested, will be implemented in 2010. DSM will do its utmost to limit the number of forced lay-offs as much as possible. In consultation with the Labor Unions a Social Plan will be made. DSM Pharma Chemicals is part of the business group DSM Pharmaceutical Products. This business group faces limited demand from pharmaceutical companies, delay in approvals and the loss of some large contracts. These factors combined lead to increasing cost pressure. To be able to be also successful in the future, the site Venlo therefore has to optimize its cost structure. For this a so-called ?lean and mean? model has been chosen. This means that all activities at the site have been examined in detail to determine the minimum necessary occupation. All other activities will be phased out or will be incorporated at DSM Pharma Chemicals in Linz, Austria. By doing this, optimal flexibility will be realized as well as the most optimal cost structure for the site. The reorganization of the site Venlo is part of the earlier announced reduction of 1250 jobs globally, of which approximately 350 in the Netherlands. DSM Pharma Chemicals is active in custom chemical manufacturing of complex registered intermediates and active pharmaceutical ingredients (APIs). DSM ? the Life Sciences and Materials Sciences Company Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSM?s products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM has annual net sales of EUR 9.3 billion and employs some 23,500 people worldwide. The company is headquartered in the Netherlands, withlocations on five continents. DSM is listed on Euronext Amsterdam. For more information please visit www.dsm.com For more information: DSM Nederland Communicatie Nelleke Barning tel. +31 (0) 46 4773343 e-mail communicatie.nederland@dsm.com [HUG#1362506] Press Release: http://hugin.info/139447/R/1362506/332603.pdf